Dividends Calendar Earnings Calendar
RUBY

RUBY | Rubius Therapeutics Inc

Rubius Therapeutics Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 1.97B
  • Prev closed: 15.89
  • Open: 16.16
  • High: 17.2
  • Low: 15.9
  • 52 week low: 3.35
  • 52 week high: 17.2
  • Dividends:No Dividends

Next ER: August 9, 2021  Before Market Opens



Top Stories (RUBY)

    Company Profile

    Rubius Therapeutics developed our proprietary RED PLATFORM® to generate red blood cells and genetically engineer them into a new class of cellular medicines, called Red Cell Therapeutics™ (RCTs). Our RED PLATFORM harnesses both the unique properties of red blood cells and the creative potential of genetic engineering to deliver on the promise of cellular therapy and transform how diseases are treated.

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    August 9, 2021-0.56 / -0.4887- / -
    May 10, 2021-0.51 / -0.5167- / -
    February 23, 2021-0.5 / -0.526- / -
    November 9, 2020-0.51 / -0.4717- / -
    August 10, 2020-0.47 / -0.49- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Sep 3, 2021 22.33 22.62
    22.89
    22.01
    242.94K -2.06%
    Sep 2, 2021 22.80 22.53
    23.18
    22.40
    322.73K 2.15%
    Sep 1, 2021 22.32 21.46
    22.47
    21.46
    286.54K 2.76%
    Aug 31, 2021 21.72 21.61
    22.14
    21.35
    308.97K 0.46%
    Aug 30, 2021 21.62 22.83
    22.98
    21.40
    258.96K -4.63%
    Aug 27, 2021 22.67 21.02
    22.82
    21.00
    447.89K 7.95%
    Aug 26, 2021 21.00 21.43
    21.79
    20.87
    281.51K -2.01%
    Aug 25, 2021 21.43 20.99
    21.53
    20.65
    334.99K 2.39%
    Aug 24, 2021 20.93 21.24
    21.65
    20.56
    302.97K -1.27%
    Aug 23, 2021 21.20 20.60
    21.82
    20.53
    586.02K 3.92%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2013
    • Employees:204

    News

    News for (RUBY)

    This company doesn't provide a dividend.

    Key Persons

    • CEO :  Pablo J Cagnoni

    Talk about Rubius Therapeutics Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Aug 9, 2021 (Same day)

    tsn apd cf dish enr acm iii cara elan ttd ceva ddd 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 33
    HOLD 67
    SELL 0

    Their Official Profiles 

    TwitterLinkedInYoutube

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Swing Trading For Dummies
    Buy on Amazon

    Want to know the strategies of successful swing trading? This friendly guide covers the ins and outs of this risky but profitable investing approach, explaining all the basics in plain English. You'll see how to use the two investment approaches - technical and fundamental analysis - to indentify promising securities in strongly trending markets. In addition, this guide covers how to calculate investment returns and, most important, how to manage your portfolio's risk.

    Take advantage of price swings in strongly trending securities and pump up your portfolio!